| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |